Patents by Inventor Eugene Mandrea

Eugene Mandrea has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF STIMULATING IMMUNE RESPONSE IN VIRALLY INFECTED INDIVIDUALS
    Publication number: 20110182829
    Abstract: The present invention is directed to a method of increasing the time period between outbreaks of genital herpes comprising providing an imidazoquinolinamine formulation, disposing an amount of the imidazoquinolinamine formulation into a first nare of an individual infected with Herpes Simplex Virus type 2, covering at least a portion of the internal surface of the individual's first nare with a portion of the amount of the imidazoquinolinamine in the nare, massaging the portion of the amount of the imidazoquinolinamine into the internal surface of the first nare, disposing the amount of the imidazoquinolinamine formulation into a second nare of the individual, covering at least a portion of the internal surface of the second nare with a portion of the amount of the imidazoquinolinamine in said nare and massaging the portion of the amount of the imidazoquinolinamine into the internal surface of said nare.
    Type: Application
    Filed: February 21, 2011
    Publication date: July 28, 2011
    Inventor: Eugene Mandrea
  • Methods of stimulating immune response in certain individuals
    Publication number: 20110178116
    Abstract: The present invention is directed to a method of increasing the time period between outbreaks of genital herpes comprising providing an imidazoquinolinamine formulation, disposing an amount of the imidazoquinolinamine formulation into a first nare of an individual infected with Herpes Simplex Virus type 2, covering at least a portion of the internal surface of the individual's first nare with a portion of the amount of the imidazoquinolinamine in the nare, massaging the portion of the amount of the imidazoquinolinamine into the internal surface of the first nare, disposing the amount of the imidazoquinolinamine formulation into a second nare of the individual, covering at least a portion of the internal surface of the second nare with a portion of the amount of the imidazoquinolinamine in said nare and massaging the portion of the amount of the imidazoquinolinamine into the internal surface of said nare.
    Type: Application
    Filed: February 21, 2011
    Publication date: July 21, 2011
    Inventor: Eugene Mandrea
  • Method of treating genital herpes
    Patent number: 7893083
    Abstract: The present invention is directed to a method of increasing the time period between outbreaks of genital herpes comprising providing an imidazoquinolinamine formulation, disposing an amount of the imidazoquinolinamine formulation into a first nare of an individual infected with Herpes Simplex Virus type 2, covering at least a portion of the internal surface of the individual's first nare with a portion of the amount of the imidazoquinolinamine in the nare, massaging the portion of the amount of the imidazoquinolinamine into the internal surface of the first nare, disposing the amount of the imidazoquinolinamine formulation into a second nare of the individual, covering at least a portion of the internal surface of the second nare with a portion of the amount of the imidazoquinolinamine in said nare and massaging the portion of the amount of the imidazoquinolinamine into the internal surface of said nare.
    Type: Grant
    Filed: May 1, 2008
    Date of Patent: February 22, 2011
    Inventor: Eugene Mandrea
  • METHOD OF TREATING GENITAL HERPES
    Publication number: 20080269274
    Abstract: The present invention is directed to a method of increasing the time period between outbreaks of genital herpes comprising providing an imidazoquinolinamine formulation, disposing an amount of the imidazoquinolinamine formulation into a first nare of an individual infected with Herpes Simplex Virus type 2, covering at least a portion of the internal surface of the individual's first nare with a portion of the amount of the imidazoquinolinamine in the nare, massaging the portion of the amount of the imidazoquinolinamine into the internal surface of the first nare, disposing the amount of the imidazoquinolinamine formulation into a second nare of the individual, covering at least a portion of the internal surface of the second nare with a portion of the amount of the imidazoquinolinamine in said nare and massaging the portion of the amount of the imidazoquinolinamine into the internal surface of said nare.
    Type: Application
    Filed: May 1, 2008
    Publication date: October 30, 2008
    Inventor: Eugene Mandrea
  • Methods of stimulating immune response in certain individuals
    Publication number: 20060183767
    Abstract: Methods to stimulate host immune system against viral infections are disclosed. Methods to stimulate immune response of a virally, influenza or cancer infected individual through an immunomodifier such as a non-nucleoside imidazoquinolinamine (heterocyclic amine) are disclosed.
    Type: Application
    Filed: December 21, 2005
    Publication date: August 17, 2006
    Inventor: Eugene Mandrea
  • Methods of stimulating immune response in virally infected individuals
    Publication number: 20050267144
    Abstract: Methods to stimulate host immune system against viral infections associated with common colds are disclosed. Methods to stimulate immune response of a virally infected individual through an immuno modifier such as a non-nucleoside imidazoquinolinamine (heterocyclic amine) are disclosed.
    Type: Application
    Filed: April 19, 2005
    Publication date: December 1, 2005
    Inventor: Eugene Mandrea
  • Methods of stimulating immune response in virally infected individuals
    Publication number: 20040136917
    Abstract: Methods to stimulate host immune system against viral infections associated with common colds are disclosed. Methods to stimulate immune response of a virally infected individual through an immuno modifier such as a non-nucleoside imidazoquinolinamine (heterocyclic amine) are disclosed.
    Type: Application
    Filed: January 5, 2004
    Publication date: July 15, 2004
    Inventor: Eugene Mandrea